MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Domain Associates LLC - CCF
Organization & Developments: Domain Associates
Parents
Domain Associates LLC - CCF
Children
2008: Clovis raised a $146 million Series A round in 2008 from Domain Associates (20.2% pre-IPO stake), New Enterprise Associates (20.2%), Versant Ventures (14.4%), Aberdare Ventures (8.7%), Abingworth (8.7%) and ProQuest Investments.
2011: Meritech Capital Partners led Glaukos’ latest funding, with Versant Venture Management LLC, and Domain Associates (2011)
2012: $13 million Series B, Domain Associates, Roche Venture Fund, Pfizer Venture Investments
2013: In this round, investors Amgen Ventures (Nasdaq: AMGN), Celgene Corporation (Nasdaq: CELG), and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers,(2013)
2014: Prior to the offering the company’s biggest stakeholders were Domain Associates (16.8 percent), Skyline Ventures (14.7 percent), Deerfield Management (13.4 percent), RA Capital (13.4 percent), Abingworth Management (10.3 percent), Brookside Capital (
2014: Venture firms that still have a stake in Cadence include Domain Associates, Frazier Healthcare Ventures, Wellington Management, Versant Ventures, Bay City Capital, and NEA
A slew of names linked to venture capital firms are listed on the filing, from the likes of Kleiner Perkins Caufield & Byers, New Enterprise Associates, Angel Medical Systems, Cutlass Capital and Domain Associates.
Amount: $5M Round: Series C Past Investor(s) Domain Associates, Scale Venture Partners, Essex Woodland Health Ventures, Synergy Life Science Partners
aTyr Pharma has just raised $23 million in Series C financing from Domain Associates, Alta Partners, Cardinal Partners and Polar
Backed by the likes of New Enterprise Associates, Polaris Venture Partners, Foundation Medical Partners and Domain Associates
Domain Associates
Domain Associates LLC, Frazier Healthcare Ventures, InterWest Partners, Meritech Capital, Montreux Equity Partners, OrbiMed Advisors LLC, Versant Venture Management LLC
Domain Associates of Princeton, N.J., and San Diego was the lead investor in the financing, which also included new investor Gund Investment Corp. of Princeton. Existing investors Battelle Ventures, Innovation Valley Partners, and KT Venture Group also par
Essex Woodlands Health Ventures led the second tranche, which was joined by existing investors Novo A/S, Domain Associates, Latterell Venture Partners, Royal Bank of Canada, The Vertical Group, and Lansing Brown Investments
Existing investors Alta Partners and Domain Associates participated in the round, as well as a new investor AKS Capital
Existing Investors include Delphi Ventures, Domain Associates, HLM Venture Partners, Second Technology Capital Investors, and TPG Biotech.
Filing doesn’t say who invested, people on its board include Amylin Pharmaceuticals founder Howard “Ted” Greene, and venture capitalists from Delhi Ventures, HLM Venture Partners, TPG Biotech, and Domain Associates.
Financing led by InterWest Partners, Domain Associates, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners.
GenVault head raised $46 million in venture funding from Cross Creek Capital, Domain Associates, Greenspring Associates, and QuestMark Partners
Included the original Series A investors, Pappas Ventures, Domain Associates, Pearl Street Venture Funds, and Triathlon Medical Ventures.
IntegenX has now raised $38.2 million in total from Domain Associates, In-Q-Tel, Rona Syndicates, Samsung Ventures America, and Western Technology Investment (2011)
InterWest Partners (Menlo Park, California) led the $16.5 million Series C financing with previous investors, Domain Associates (Princeton, New Jersey) and Okapi Venture Capital (Laguna Beach, California), also participating.
Investor(s) MB Venture Partners, Split Rock Partners, Domain Associates
Investor(s) Partners Healthcare Innovation Fund, Versant Ventures, Accuitive Medical Ventures, Domain Associates
Investor(s) : Versant Ventures, Domain Associates, The Foundry
Investors Essex Woodlands Health Ventures, Morgenthaler Ventures, Domain Associates, and BioStar.
Investors include Domain Associates, Delphi Ventures, De Novo Ventures and Johnson & Johnson Development Corporation.
Investors include Domain Associates, Latterell Venture Partners, and Windamere Venture Partners.
Investors include Meritech Capital Partners, Venrock and Domain Associates
Investors include New Enterprise Associates, Domain Associates LLC and SonoSite Inc.
Investors: Domain Associates, Versant Ventures
Investors: Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and the Wellcome Trust
Investors:Domain Associates LLC, Kleiner Perkins Caufield & Byers, TPG Biotech, Versant Venture Management LLC
It counts Quaker BioVentures, Ventures West, Domain Associates and GrowthWorks among its 10 investors.
Major investors include Domain Associates, New Enterprise Associates and SonoSite, Inc.
New investor Domain Associates, LLC, led the round, joined by existing investors who include CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.
New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.
New investors Aisling Capital and Cross Creek Capital led the round, which was joined by existing investors Domain Associates and Morgenthaler Ventures.
Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners
Participants include SR One, Domain Associates, Oxford Bioscience Partners, Abingworth Management and Skyline Ventures.
Participating in the financing were Durham-based Pappas Ventures Pappas Ventures Latest from The Business Journals CoLucid closes in on .5 millionCED picks Pappas, Channel Advisor execsLipoScience files for M IPO Follow this company , Domain Associates,
Past Investor(s) : New Enterprise Associates, InterWest Partners, MedVenture Associates, Domain Associates, Johnson & Johnson, Technology Partners
Raised $15.6 million in new capital in a round led by existing investor Domain Associates (2011)
Series B $38.5 million. Investors: Novo Ventures, RiverVest Venture Partners, Avalon Ventures, Domain Associates, TPG Biotech (2
The company’s investors include Advanced Technology Ventures, Cutlass Capital, Domain Associates, Johnson & Johnson Development, Polaris Venture Partners, and Seedling Enterprises
The round was co-led by new investors, San Diego-based Domain Associates and Palo Alto-based Technology Partners. Also participating were Versant Ventures and DeNovo Ventures.
U.S. Venture Partners, Delphi Ventures and Domain Associates
Jumps
*Key People: Domain Associates
Finance & Acquisitions: Domain Associates